CF
ETNB

Corebridge Financial’s 89bio ETNB Stock Holding History

Corebridge Financial’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-54,823
Closed -$399K – 909
2025
Q1 		$399K Buy
54,823
+13,201
+32% +$115K ﹤0.01% 1715
2024
Q4 		$325K Sell
41,622
-3,141
-7% -$25.9K ﹤0.01% 1900
2024
Q3 		$331K Buy
44,763
+1,170
+3% +$9.84K ﹤0.01% 1941
2024
Q2 		$349K Buy
+43,593
New +$389K ﹤0.01% 1888

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Corebridge Financial's ETNB Position: Q2 2025 in Review

Corebridge Financial sold out of 89bio (ETNB) in Q2 2025, closing a stake of 54,823 shares — an estimated $399K sold.

Corebridge Financial first reported a position in ETNB in Q2 2024 and held it in 4 quarters. The position peaked at $399K in Q1 2025. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • Corebridge Financial reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 54,823 89bio shares in Q2 2025, an estimated $399K.
  • Corebridge Financial first reported a position in 89bio in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's 89bio position peaked at $399K in Q1 2025.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.